Fingerprint
Dive into the research topics of 'High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically